Why do we need this research?
Premature birth can lead to health problems for both mother and baby. There are ways that doctors can help mothers who are showing signs that they might give birth early. These interventions can delay labour, or reduce the health risks linked with premature birth. However, for these interventions to be most effective, they need to be given at the right time before delivery.
Too often, mothers are transferred to specialist neonatal units before they really need to. This can put pressure on the health service, and prevent other patients getting the care they need. It can also cause stress and anxiety for the mother and her family.
We need better ways to predict how likely a mother is to go into premature labour, so that they can get the right care at the right time.
What’s happening in this project?
Researchers supported by Tommy’s have developed the QUIPP app, which can help doctors predict the chances of premature birth. The aim of the app is to help them decide which women need further medical help, and which don’t. It works by looking at different measures, including the levels of a protein called fetal fibronectin in the woman’s vagina, the length of her cervix, and any previous history of premature birth.
To find out whether the QUIPP app really is effective, our researchers have now set up the EQUIPTT trial to test if it helps doctors to make better decisions for the care of women at risk of premature birth. The team have recruited more than 2,400 women to take part in the EQUIPTT study, from 14 maternity units across England. In half of these units, doctors used the QUIPP app to calculate the chance that a woman will give birth in the next seven days. Our researchers are also assessing whether the app helps to reduce anxiety in mothers at risk of premature birth.
The data from the study is currently being analysed, and the results should be announced in 2020.
What difference will this project make?
The EQUIPTT study will find out whether the QUIPP app helps doctors make decisions about the care of women at risk of premature labour. If successful, this app will help reduce unnecessary interventions, and ensure that the women who really do need treatment get it as soon as possible. This will improve the chances of them giving birth to a healthy baby.
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. If you're interested in being kept updated about our research and news from Tommy's, click here.
More research projects
New research has revealed the benefits of giving progesterone to women with early pregnancy bleeding and a history of miscarriage.
Tommy’s spent yesterday morning at the charming Foundling Museum in London, celebrating the work of Tommy’s National Centre for Maternity Improvement alongside the opening of the museum’s new exhibition, ‘Portraying Pregnancy’.
Miscarriage and ectopic pregnancy may trigger long-term post-traumatic stress, anxiety and depression
The largest ever study into the psychological impact of miscarriage and ectopic pregnancy has shown that early-stage pregnancy loss can have a serious impact on mental health. The research was led by Professor Tom Bourne at the Tommy’s National Centre for Miscarriage Research at Imperial College London.
A pilot trial led by Tommy’s National Centre for Miscarriage Research suggests diabetes drug could be repurposed to target the lining of the womb in women with recurrent miscarriage.